Literature DB >> 21152884

[Vaccination under immunosuppressive therapy of chronic inflammatory diseases].

M Weisser1.   

Abstract

Immune-mediated inflammatory diseases and applied immunosuppressive or modulating medications predispose patients for more frequent and more severe infections. Partly, these can be prevented by vaccinations. However immunization rates in daily life are low. The indication for vaccination, the capacity of sufficient antibody response and possible adverse reactions--such as vaccination-induced infection in live-vaccines--must be carefully evaluated and timing should be planned accordingly. In addition to vaccinations according general recommendation patients with immunosuppression benefit from vaccinations against seasonal influenza and S. pneumoniae. Induction of flares of the underlying disease after vaccination could not be confirmed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21152884     DOI: 10.1007/s00108-010-2680-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  44 in total

Review 1.  Infections and SLE.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Autoimmunity       Date:  2005-11       Impact factor: 2.815

2.  Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.

Authors:  Gil Y Melmed; Andrew F Ippoliti; Konstantinos A Papadakis; Tram T Tran; Jaime L Birt; Susie K Lee; Robert W Frenck; Stephan R Targan; Eric A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2006-06-30       Impact factor: 10.864

3.  Effects of long-term low-dose corticosteroid therapy on humoral immunity.

Authors:  Mary E Fedor; Arye Rubinstein
Journal:  Ann Allergy Asthma Immunol       Date:  2006-07       Impact factor: 6.347

4.  Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  Ori Elkayam; Daphna Paran; Dan Caspi; Irena Litinsky; Michael Yaron; Darlene Charboneau; Jeffrey B Rubins
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

5.  Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.

Authors:  A Chalmers; D Scheifele; C Patterson; D Williams; J Weber; R Shuckett; A Teufel
Journal:  J Rheumatol       Date:  1994-07       Impact factor: 4.666

6.  Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood.

Authors:  Zhanguo Liu; Xiaopeng Yuan; Yuwei Luo; Yi He; Yong Jiang; Zhonghua Klauz Chen; Erwei Sun
Journal:  Cytokine       Date:  2009-01-09       Impact factor: 3.861

7.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

8.  Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.

Authors:  Sudha Visvanathan; Gregory F Keenan; Daniel G Baker; Arnold I Levinson; Carrie L Wagner
Journal:  J Rheumatol       Date:  2007-04-15       Impact factor: 4.666

9.  The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes.

Authors:  Philippe Georgel; Cécile Macquin; Seiamak Bahram
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

Review 10.  Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Authors:  C Salliot; M Dougados; L Gossec
Journal:  Ann Rheum Dis       Date:  2008-01-18       Impact factor: 19.103

View more
  1 in total

1.  [Alemtuzumab: a further option for treatment of multiple sclerosis].

Authors:  T Menge; B C Kieseier; C Warnke; O Aktas; H-P Hartung
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.